Post by
Duster340 on Nov 09, 2023 10:30am
Looks Like 🚩
the run is done. looking ahead to the financials next week i do not see any possitive catalyst. only potential negatives
> no firm date set for P2 all we no is it is scheduled for Q1 2024, could it get pushed back (yes)
> will there be a cash raise announced?
> maybe negative news with the nuance pharma dispute
likely more selling after the financials report